Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis

Authors

Wilma A. Stolk, University Medical Center Rotterdam
Quirine A. ten Bosch, University Medical Center Rotterdam
Sake J. de Vlas, University Medical Center RotterdamFollow
Peter U. Fischer, Washington University School of Medicine in St. Louis
Gary J. Weil, Washington University School of Medicine in St. Louis
Ann S. Goldman, George Washington University - School of Medicine and Health Sciences

Journal

PLoS Neglected Tropical Diseases

Publication Date

2013

Volume

7

Issue

1

Inclusive Pages

e1984

Document Type

Open Access Publication

DOI

10.1371/journal.pntd.0001984

Rights and Permissions

Stolk WA, ten Bosch QA, de Vlas SJ, Fischer PU, Weil GJ, et al. (2013) Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis. PLoS Negl Trop Dis 7(1): e1984. doi:10.1371/journal.pntd.0001984

Recommended Citation

Stolk, Wilma A.; ten Bosch, Quirine A.; de Vlas, Sake J.; Fischer, Peter U.; Weil, Gary J.; and Goldman, Ann S., "Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis." PLoS Neglected Tropical Diseases. 7, 1. e1984. (2013).
https://digitalcommons.wustl.edu/open_access_pubs/1351